All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • GST101Phase 21 trial

    Genuine Seed Therapeutics (Zhuhai) Co., Ltd. · RAS-mutant Advanced Solid Tumors

  • GT-02287GT-02287 400, GT-02287 800Phase 21 trial

    Gain Therapeutics, Inc. · Parkinson Disease

  • GT101Phase 21 trial

    Grit Biotechnology · Recurrent or Metastatic Cervical Cancer

  • GT719Phase 21 trial

    Grit Biotechnology · Hematological Malignancy (Leukemia- Lymphoma)

  • GTAEXS617REC-617Phase 21 trial

    Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC)

  • GTX-102Phase 21 trial

    Ultragenyx Pharmaceutical Inc · Angelman Syndrome

  • GVB-2001Phase 21 trial

    IVIEW Therapeutics Inc. · Primary Open-Angle Glaucoma (POAG)

  • GVV858Phase 21 trial

    Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer

  • GXV813Phase 21 trial

    Novartis · Schizophrenia

  • GZR101-80Phase 21 trial

    Gan & Lee Pharmaceuticals. · Type 2 Diabetes (T2DM)

  • GZR102Phase 21 trial

    Gan & Lee Pharmaceuticals. · Type 2 Diabetes Mellitus (T2DM)

  • H001Phase 21 trial

    Livzon Pharmaceutical Group Inc. · Circulatory Disease

  • HA131Phase 21 trial

    CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Advanced Hepatocellular Carcinoma (HCC)

  • HB-201HB-202 alternating using CD8 PET Tracer, Zr-Df-IAB22M2CPhase 21 trial

    Hookipa Biotech GmbH · HPV-Related Squamous Cell Carcinoma

  • HB-202Phase 21 trial

    Hookipa Biotech GmbH · HPV-Related Squamous Cell Carcinoma

  • HB0017Phase 21 trial

    Huabo Biopharm Co., Ltd. · Psoriasis (PsO)

  • HB0034Phase 21 trial

    Shanghai Huaota Biopharmaceutical Co., Ltd. · Generalized Pustular Psoriasis (GPP)

  • HB0036Phase 21 trial

    Shanghai Huaota Biopharmaceutical Co., Ltd. · Advanced Solid Tumor, NSCLC

  • HB0052Phase 21 trial

    Shanghai Huaota Biopharmaceutical Co., Ltd. · Solid Tumors

  • HBI-3000sulcardine sulfatePhase 21 trial

    HUYABIO International, LLC. · Atrial Fibrillation

  • HC010Phase 21 trial

    HC Biopharma Inc. · NSCLC

  • HCB101Phase 21 trial

    FBD Biologics Limited · Solid Cancer

  • HCW9218Phase 21 trial

    ImmunityBio, Inc. · Advanced Pancreatic Carcinoma

  • HD-6277Phase 21 trial

    Hyundai Pharm · Type 2 Diabetes Mellitus (T2DM)

  • HDM2005Phase 21 trial

    Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Diffuse Large B Cell Lymphoma (DLBCL)

  • HDP-101Phase 21 trial

    Heidelberg Pharma AG · Multiple Myeloma, Plasma Cell Disorder

  • HEC53856Phase 21 trial

    Sunshine Lake Pharma Co., Ltd. · Chemotherapy-induced Anemia, Non-Myeloid Malignancy

  • HEC88473Phase 21 trial

    Dongguan HEC Biopharmaceutical R&D Co., Ltd. · Type 2 Diabetes

  • HeXell-2020Phase 21 trial

    Hexun Biosciences Co., LTD. · Coronary Artery Disease

  • HG146Phase 21 trial

    HitGen Inc. · Adenoid Cystic Carcinoma, Head and Neck Cancer

  • HGT-1110Recombinant human arylsulfatase APhase 21 trial

    Takeda · Metachromatic Leukodystrophy (MLD)

  • HH-006Phase 21 trial

    Huahui Health · Chronic Hepatitis B Virus Infection

  • HK-660SPhase 21 trial

    CuromeBiosciences · Primary Sclerosing Cholangitis (PSC)

  • HL-085Phase 21 trial

    Shanghai Kechow Pharma, Inc. · Neurofibromatosis 1, Plexiform Neurofibromas

  • HL-300Phase 21 trial

    Hangzhou Highlightll Pharmaceutical Co., Ltd · Atopic Dermatitis

  • HLX-1502Phase 21 trial

    Healx Limited · Neurofibromatosis Type 1

  • HLX01Phase 21 trial

    Shanghai Henlius Biotech · Membranous Nephropathy, Lupus Nephritis (LN)

  • HLX26Phase 21 trial

    Shanghai Henlius Biotech · NSCLC Stage IV

  • HLX53Phase 21 trial

    Shanghai Henlius Biotech · Carcinoma, Hepatocellular

  • HLX79Phase 21 trial

    Shanghai Henlius Biotech · Membranous Nephropathy, Lupus Nephritis (LN)

  • HM15136Phase 21 trial

    Hanmi Pharmaceutical Company Limited · Congenital Hyperinsulinism

  • HM15421GC1134APhase 21 trial

    GC Biopharma Corp · Fabry Disesase

  • HMB-001Phase 21 trial

    Hemab ApS · Glanzmann Thrombasthenia

  • HMB-002Phase 21 trial

    Hemab ApS · Von Willebrand Disease (VWD), Von Willebrand Disease (VWD), Type 1, Von Willebrand Disease (VWD), Type 2

  • HMBD-001Phase 21 trial

    Hummingbird Bioscience · Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma

  • HMPL-689Phase 21 trial

    Hutchmed · Relapsed/Refractory Lymphoma

  • HP-002Phase 21 trial

    Shanghai Helioson Pharmaceutical Co., Ltd. · B-Cell Non-Hodgkin Lymphoma

  • HP-211Phase 21 trial

    Housey Healthcare ULC · Type 2 Diabetes

  • HP515Phase 21 trial

    Hinova Pharmaceuticals Inc. · NAFLD (Non-alcoholic Fatty Liver Disease)

  • HP518Phase 21 trial

    Hinova Pharmaceuticals Inc. · Metastatic Castration-resistant Prostate Cancer

NewerPage 55 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.